ABMT (Advanced BioMedical Technologies) Interest Expense: $-0.31 Mil (TTM As of Jul. 2021)


What is Advanced BioMedical Technologies Interest Expense?

Advanced BioMedical Technologies ABMT Interest Expense is $-0.31 Mil as of Jul. 2021.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Advanced BioMedical Technologies's interest expense for the three months ended in Jul. 2021 was $ -0.08 Mil. Its interest expense for the trailing twelve months (TTM) ended in Jul. 2021 was $-0.31 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Advanced BioMedical Technologies's Operating Income for the three months ended in Jul. 2021 was $ -0.11 Mil. Advanced BioMedical Technologies's Interest Expense for the three months ended in Jul. 2021 was $ -0.08 Mil. Advanced BioMedical Technologies did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Advanced BioMedical Technologies  (OTCPK:ABMT) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Advanced BioMedical Technologies's Interest Expense for the three months ended in Jul. 2021 was $-0.08 Mil. Its Operating Income for the three months ended in Jul. 2021 was $-0.11 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Jul. 2021 was $0.00 Mil.

Advanced BioMedical Technologies's Interest Coverage for the quarter that ended in Jul. 2021 is calculated as

Advanced BioMedical Technologies did not have earnings to cover the interest expense.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Advanced BioMedical Technologies Interest Expense Historical Data

* Premium members only.

The historical data trend for Advanced BioMedical Technologies's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Advanced BioMedical Technologies Interest Expense Chart

Advanced BioMedical Technologies Annual Data
Trend Oct11 Oct12 Oct13 Oct14 Oct15 Oct16 Oct17 Oct18 Oct19 Oct20
Interest Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.25 -0.26 -0.30 -0.33 -0.33

Advanced BioMedical Technologies Quarterly Data
Oct16 Jan17 Apr17 Jul17 Oct17 Jan18 Apr18 Jul18 Oct18 Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.08 -0.08 -0.08 -0.08 -0.08

Advanced BioMedical Technologies Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Jul. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.31 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Interest Expense →
What does a Interest Expense of $-0.31 Mil mean?
Advanced BioMedical Technologies (ABMT) has a Interest Expense of $-0.31 Mil as of Jul. 2021. Interest Expense is the amount a company pays on its long-term debt. View historical data on Advanced BioMedical Technologies and its competitors.
Is Advanced BioMedical Technologies' Interest Expense too high?
Advanced BioMedical Technologies' current Interest Expense is $-0.31 Mil.
How does Advanced BioMedical Technologies' Interest Expense compare to VYCO and ADMT?
Advanced BioMedical Technologies' Interest Expense of $-0.31 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Expense for a Medical Devices & Instruments company?
A good Interest Expense depends on the Medical Devices & Instruments industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Expense mean?
A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on Advanced BioMedical Technologies and its competitors. Advanced BioMedical Technologies's current Interest Expense is $-0.31 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Advanced BioMedical Technologies stock overvalued right now?
Advanced BioMedical Technologies (ABMT) has a current Interest Expense of $-0.31 Mil. The current Interest Expense is $-0.31 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Expense calculated?
Interest Expense is calculated from a company's financial statements. For Advanced BioMedical Technologies (ABMT), the current Interest Expense is $-0.31 Mil as of Jul. 2021. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Advanced BioMedical Technologies Business Description

Address 535 Fifth Avenue, 4th Floor, New York, NY, USA, 10017
Advanced BioMedical Technologies Inc is engaged in designing, developing, manufacturing, and the planned future marketing of self-reinforced, re-absorbable, biodegradable internal fixation devices. The company manufactures its products using Polyamide, and it is used in a variety of applications, which include orthopaedic trauma, sports-related medical treatment, cartilage injuries, and reconstructive dental procedures. Its Polyamide products include screws, rods, and binding wires consisting of enhanced fibres and high molecular polymers, which are designed to facilitate quick healing of complex fractures in many areas of the human skeletal system.